Israel stocks higher at close of trade; TA 35 up 0.48% By

© Reuters. Israel stocks higher at close of trade; TA 35 up 0.48% – Israel stocks were higher after the close on Thursday, as gains in the , and sectors led shares higher.

At the close in Tel Aviv, the gained 0.48%.

The best performers of the session on the were OPKO Health Inc (TASE:), which rose 7.95% or 140 points to trade at 1900 at the close. Meanwhile, Ormat Technologies (TASE:) added 5.44% or 2000 points to end at 38770 and Teva Pharmaceutical Industries Ltd (TASE:) was up 3.14% or 124 points to 4068 in late trade.

The worst performers of the session were Energix (TASE:), which fell 2.29% or 29 points to trade at 1240 at the close. First International Bank of Israel Ltd (TASE:) declined 2.00% or 177 points to end at 8662 and Melisron (TASE:) was down 1.68% or 290 points to 17000.

Falling stocks outnumbered advancing ones on the Tel Aviv Stock Exchange by 259 to 165 and 21 ended unchanged.

Shares in Ormat Technologies (TASE:) rose to all time highs; rising 5.44% or 2000 to 38770.

Crude oil for March delivery was down 0.76% or 0.40 to $52.45 a barrel. Elsewhere in commodities trading, Brent oil for delivery in April fell 0.56% or 0.31 to hit $55.22 a barrel, while the April Gold Futures contract rose 0.45% or 8.25 to trade at $1857.15 a troy ounce.

USD/ILS was up 0.55% to 3.2828, while EUR/ILS rose 0.63% to 3.9809.

The US Dollar Index Futures was down 0.16% at 90.493.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.